Zenith Health Care Ltd.
Snapshot View

View in App

Prices View details >>

4.42 +0.20 ▲4.7%

24 March 2023, 04:01:00 PM
Volume: 42,509

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zenithhealthcare.com
Market Cap 23.75 Cr.
Enterprise Value(EV) 22.05 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.02 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 194.69 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 1.39 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.19 Calculated using Price: 4.42
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 5.37 Cr. 53,739,000 Shares
FaceValue 1
Company Profile
Zenith Healthcare is engaged in the manufacturing of tablets, capsules, ointments, and liquid injectable among others.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.74%
1 Week
+15.10%
1 Month
+9.14%
3 Month
-21.21%
6 Month
-22.73%
1 Year
-40.27%
2 Year
-27.90%
5 Year
+505.48%
10 Year
+820.83%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -4.37 -4.06 -5.45 -2.78 4.95 2.38 9.27 6.64 4.44
Return on Capital Employed (%) -6.48 -5.82 -8.24 -3.04 7.38 2.95 9.68 8.56 8.85
Return on Assets (%) -3.90 -3.73 -5.00 -2.55 4.37 2.03 7.60 5.28 3.11

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 6 6 6 5 6 6 6 7 7 7
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 1 1 1 1 2 2 5 3
Minority Int.
Equity & Liab. 7 6 6 6 7 7 8 8 12 11
Non Curr. Assets 3 3 2 2 2 2 2 2 2 2
Curr. Assets 4 4 4 4 5 5 6 6 10 9
Misc. Exp. not W/O
Total Assets 7 6 6 6 7 7 8 8 12 11

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 3 4 3 5 10 10 12 14 22 19
Other Income 0 0 0 0 0 0 0 1 1 0
Total Income 3 4 4 5 10 10 12 14 23 20
Total Expenditure -4 -4 -4 -5 -9 -10 -11 -13 -22 -19
PBIDT 0 0 0 0 1 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items 0
PAT 0 0 0 0 0 0 1 0 0 0
Adjusted EPS 0 0 0 0 0 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 1 0 2 -1 1
Cash Fr. Inv. 0 0 0 0 0 0 0 -1 0 0
Cash Fr. Finan. 0 0 0 0
Net Change 0 -1 0 0 0 0 0 1 -2 1
Cash & Cash Eqvt 1 0 0 1 1 1 1 2 1 2

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 28.74 28.74 28.74 28.74 28.74 28.74 28.74 28.74 28.74
Public 71.26 71.26 71.26 71.26 71.26 71.26 71.26 71.26 71.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 17 Mar 2023
Board Meeting Intimation for NOTICE OF INDEPENDENT DIRECTORS MEETING
ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2023 inter alia to consider and approve The meeting of the Independent Directors of the Company will be held on Tuesday 28th March 2023 at 5.00. P.M. at the Registered Office of the Company to transact the following businesses: 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To review the performance of Chairman (elected) of the Company taking into account the views of executive directors and non-executive directors.3. To access the Quality Quantity and timeliness of flow of Information between the management of the company and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties.4. Any other Business with the permission of the Chair.
Mon, 13 Feb 2023
Board Meeting Outcome for Unaudited Standalone Financial Results For The Quarter And Nine-Months Ended December 31 2022.
Unaudited Standalone Financial Results for the Quarter and Nine-Months ended December 31 2022.
Mon, 13 Feb 2023
Unaudited Standalone Financial Results For The Quarter And Nine-Months Ended December 31 2022.
Unaudited Standalone Financial Results for the Quarter and Nine-Months ended December 31 2022.

Technical Scans View Details >>

Fri, 24 Mar 2023
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Above Last Week High Close Above Last Week High

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Zenith Health Care Ltd.

What is Zenith Health Care share price?
Can I buy Zenith Health Care shares now?
What is the Market Cap of Zenith Health Care?
What are the key metrics to analyse Zenith Health Care?
What is the 52 Week High and Low of Zenith Health Care?
What is the trend of Zenith Health Care share price?